5 completed. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 1 | 2 | Completed 2 |
Follow AZD-3199: new trials by email Literature Review of AZD-3199 trials Research Report on AZD-3199
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of the Pharmacokinetics and the Pharmacodynamics of Different Dry Powder Inhalation Formulations of AZD3199 in Patients With Asthma AZD3199, AZD3199 Placebo - Asthma | Phase 2 | Completed | AstraZeneca | 39 | 2011-05-01 | 2013-03-05 |
| To Evaluate the Effect of AZD3199 on the Electrical Activity in the Heart AZD3199, Moxifloxacin, Placebo comparator - Chronic Obstructive Pulmonary Disease, Lung Disease | Phase 1 | Completed | AstraZeneca | 40 | 2010-11-01 | 2011-02-16 |
| Efficacy of AZD3199 in Chronic Obstructive Pulmonary Disease (COPD) Patients AZD3199, formoterol, Placebo - COPD | Phase 2 | Completed | AstraZeneca | 329 | 2009-06-01 | 2014-02-17 |
| Single-dose Crossover Study to Investigate Pharmacodynamics of AZD3199 AZD3199, Formoterol, Placebo - Asthma, Airway Obstruction | Phase 2 | Completed | AstraZeneca | 37 | 2008-08-01 | 2014-05-19 |
| Multiple Ascending Doses (MAD) of AZD3199 Given Once Daily as Inhaled Formulation Via Turbuhaler to Healthy Men AZD3199, Placebo - Healthy Volunteers | Phase 1 | Completed | AstraZeneca | 27 | 2008-08-01 | 2014-04-10 |
Respiratory Aspiration (3) · Asthma (2) · Pulmonary Disease, Chronic Obstructive (2) · Airway Obstruction (1) · Bronchiolitis (1) · Emphysema (1) · Lung Diseases (1) · Respiration Disorders (1)
AstraZeneca (5)
Sweden (3) · Bulgaria (1) · Canada (1) · Denmark (1) · Japan (1) · Poland (1) · Russia (1) · United Kingdom (1)
Carin Jorup, MD (1) · Gabriella Samuelsson Palmgren (1) · Leonard Siew, MB CHB (1) · Piotr Kuna, Professor (1) · Prof Leif Bjermer, MD, PhD (1)